Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation-Reference-Cited by-同舟云学术

Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation

Published:1999-12 Issue:6 Volume:14 Page:451-463
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Saleh Mansoor N.,Raisch Kevin P.,Stackhouse Murray A.,Grizzle William E.,Bonner James A.,Mayo Matthew S.,Kim Hyung-Gyoon,Meredith Ruby F.,Wheeler Richard H.,Buchsbaum Donald J.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.1999.14.451

Reference5 articles.

1. Cell-cycle arrest versus cell death in cancer therapy

2. Which guesstimate is the best guesstimate? Predicting chemotherapeutic outcomes

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review;TRANSL CANCER RES;2024

2. Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders;Bioengineering;2024-01-09

3. EGFR Mutations in Head and Neck Squamous Cell Carcinoma;International Journal of Molecular Sciences;2022-03-30

4. Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2);Strahlentherapie und Onkologie;2020-06-12

5. Cetuximab Concurrent with Radiotherapy in Unresectable, Locally Advanced Squamous Cell Carcinoma of Head and Neck: Real-World Evidence from a Tertiary Care Hospital;Indian Journal of Otolaryngology and Head & Neck Surgery;2020-05-07